Kabir Nath

Compass cuts 30% of staff as late-stage psilocybin drug trials face new delays

Compass Pathways (NASDAQ: CMPS) plans to cut about 30% of its workforce and halt early-stage research programs as the firm focuses resources on completing late-stage...

Compass Pathways posts second-quarter loss as clinical trials advance

Compass Pathways (NASDAQ: CMPS) reported a wider loss for the second quarter ending June 30, while its late-stage clinical trials for depression treatment edge closer...

Compass Pathways keeps plugging away with its psilocybin study trials

Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the first quarter of 2024 ending in March with no revenue yet to report. The...

Compass Pathways co-founders exit to pursue ‘broader goals’

Compass Pathways plc (Nasdaq: CMPS) saw its stock price slip more than 12% on news that that its co-founders, George Goldsmith and Ekaterina Malievskaia, resigned...

Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape

Psychedelic Alpha’s Josh Hardman speaks with Compass Pathways CEO, Kabir Nath, about a range of topics: from the company’s recently-announced agreements that could shed light...

Compass Pathways Research, Clinical Trials Buoyed by Influx of New Funds

Mental health biotech firm Compass Pathways (Nasdaq: CMPS) reported its third-quarter financials ending Sept. 30, as well as the status of ongoing clinical trials. The...

Compass Pathways Loses Chief Financial Officer

Compass Pathways plc (Nasdaq: CMPS) announced that Mike Falvey, chief financial officer, will leave the company on Nov. 3 to pursue other opportunities. Mary-Rose Hughes,...

Top 10 Psychedelic Companies That Should Be on Your Radar

The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these are the companies that have shown potential...

Top 10 Psychedelic Companies That Should Be on Your Radar

The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these top 10 psychedelic companies are the companies...

Compass Pathways Gets Good News on Psilocybin Patent Journey

Compass Pathways plc (Nasdaq: CMPS) announced that the U.S. Patent Trial and Appeal Board reaffirmed decisions to uphold its ‘257 Patent and ‘259 Patent, key...

Analysts Probe Compass Pathways About Johnson & Johnson’s Spravato

As psychedelic drug companies race to get ketamine drugs approved by the FDA for drug-resistant depression, Johnson & Johnson (NYSE: JNJ) may have beat them...

Kabir Nath: our mission, progress and future perspectives

CEO, COMPASS Pathways Part of our Year in Review series As COMPASS Pathways embarks on its ambitious Phase 3 program, which will evaluate its COMP360...

Compass Names New CEO, On Track For Phase 3 Study

Psychedelic drug company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the second quarter 2022 and gave an update on recent progress across...

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) — Highlights: Kabir Nath appointed as Chief Executive Officer Phase III program submitted to FDA and under review COMP360...

COMPASS Pathways Announces Q2 Financials and Business Highlights

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights August 04, 2022 07:00 ET | Source: COMPASS Pathways Highlights: Kabir Nath appointed...

Psychedelic Sector News – Weekly Extractions: July 22, 2022

After a monumental last week for the psychedelics sector, we’re back with another edition of Weekly Extractions. In this episode, Adam Tubero reviews why you...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO - Microdose Psychedelic Insights

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers.

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

New Netflix Show Spotlights Psychedelics ... level of awareness to the life-altering possibilities of psychedelic substances as medicine.

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

COMPASS Pathways Appoints Big Pharma CEO

One of the more hopeful things about the early days of the psychedelic medicine industry was that it was founded by true believers. Despite the...

Otsuka

President & CEO

Last updated: Jun 26, 2020

Request Deletion